Senores Pharma: Cup & Handle - Ready for Some Action?

SENORES

• Senores Pharma is forming a potential cup and handle on the daily timeframe. A breakout attempt on Feb 6, 2025, failed to sustain above ₹607.35 as selling pressure came in second half.
  
• Now, the cup and handle pattern is progressing, making next week crucial. A close above ₹607.35 is the key level to watch for confirmation.
  
• Volumes are rising, with today's volume (Feb 21, 2025) nearly 5x yesterday's. The stock's resilience despite market pressure indicates strength.
  
• Cup and Handle pattern usually don't disappoint so would be interesting to watch.
  

Senores Pharmaceuticals is a research-driven company focused on developing specialty pharmaceutical products for regulated markets. The company has shown impressive financial performance:

Recent Financials (Q3 FY25):

• Net Sales: ₹106.4 crore (up 35% YoY from ₹78.7 crore in Q3 FY24)
  
• QoQ Performance: Increased from ₹104.4 crore in Q2 FY25 (up 1.92%)
  
• EBITDA: ₹29.1 crore (up 92% YoY)
  
• PAT: ₹17.2 crore (up 142% YoY from ₹7.1 crore in Q3 FY24)
  
  9MFY25 Performance:
  
• Total Revenue: ₹288.1 crore (up 157% YoY from ₹112.1 crore in 9MFY24)
  
• PAT: ₹40.7 crore (up 162% YoY)
  

Market Position: The stock has outperformed its sector and the broader Sensex, achieving consecutive gains over the past month and trading above multiple moving averages.

Future Projections: Management anticipates a top-line growth of 50%-60% for FY26, with plans to launch five new products in the current quarter.

Strategic Focus: Continued investment in R&D and infrastructure development is expected to enhance manufacturing capabilities and expand product offerings.